article Open AccessTop 1% cited
Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
Nephrology Dialysis Transplantation · 2006 · Vol. 21(4) · pp. 1104–1108
Thomas Grobner✉(Fachhochschule Wiener Neustadt)
Lanthanide and Transition Metal ComplexesSympathectomy and Hyperhidrosis TreatmentsBiomedical Research and PathophysiologyNephrogenic systemic fibrosisMedicineGadoliniumFibrosisPathologyKidney diseaseInternal medicine
MeSH terms
AdultAgedContrast MediaFemaleFibrosisHumansKidney Failure, ChronicMaleMiddle AgedSkin DiseasesGadolinium DTPA
Citations
1,830
FWCI
101.16
field-weighted impact
References
21
Percentile
100%
vs. same field & year
Citations per year
Cited by
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
European Radiology · 2006 · 351 citations
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
American Journal of Roentgenology · 2007 · 605 citations
ACR Guidance Document for Safe MR Practices: 2007
American Journal of Roentgenology · 2007 · 782 citations
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Radiology · 2007 · 1,016 citations
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
Journal of the American Academy of Dermatology · 2006 · 541 citations
Gadolinium(iii) complexes as MRI contrast agents: ligand design and properties of the complexes
Dalton Transactions · 2008 · 515 citations
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines
European Radiology · 2012 · 431 citations
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging
Radiology · 2015 · 1,313 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.